Literature DB >> 24973761

Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.

Gema Lorenzo1, Miguel Rodríguez-Pulido2, Elena López-Gil1, Francisco Sobrino2, Belén Borrego1, Margarita Sáiz2, Alejandro Brun3.   

Abstract

In this work we have addressed the effect of synthetic, non-infectious, RNA transcripts, mimicking structural domains of the non-coding regions (NCRs) of the foot-and-mouth disease virus (FMDV) genome on the infection of mice with Rift Valley fever virus (RVFV). Groups of 5 mice were inoculated intraperitoneally (i.p.) with 200 μg of synthetic RNA resembling the 5'-terminal S region, the internal ribosome entry site (IRES) or the 3'-NCR of the FMDV genome. RNA inoculation was performed 24h before (-24 h), 24 h after (+24 h) or simultaneously to the challenge with a lethal dose of RVFV. Administration of the IRES RNA afforded higher survival rates than administration of S or 3'NCR transcripts either at -24h or +24h after challenge. In contrast, when RNA inoculation and viral challenge were performed simultaneously, all mice survived in both IRES- and 3'NCR-inoculated groups, with an 80% survival in mice receiving the S RNA. Among survivors, a complete correlation between significant anti-RVFV circulating antibody titers and resistance to a second lethal challenge with the virus was observed, supporting a limited viral replication in the RNA-inoculated animals upon the first challenge. All three RNA transcripts were able to induce the production of systemic antiviral and pro-inflammatory cytokines. These data show that triggering of intracellular pathogen sensing pathways constitutes a promising approach towards development of novel RVF preventive or therapeutic strategies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Foot and mouth disease virus; Innate immunity; Non coding RNA regions; Rift Valley fever

Mesh:

Substances:

Year:  2014        PMID: 24973761     DOI: 10.1016/j.antiviral.2014.06.010

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  4 in total

1.  Case-Control Comparison of Enteric Viromes in Captive Rhesus Macaques with Acute or Idiopathic Chronic Diarrhea.

Authors:  Beatrix Kapusinszky; Amir Ardeshir; Usha Mulvaney; Xutao Deng; Eric Delwart
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

2.  The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.

Authors:  Shoko Nishiyama; Nandadeva Lokugamage; Tetsuro Ikegami
Journal:  J Virol       Date:  2016-01-27       Impact factor: 5.103

3.  Synthetic RNAs Mimicking Structural Domains in the Foot-and-Mouth Disease Virus Genome Elicit a Broad Innate Immune Response in Porcine Cells Triggered by RIG-I and TLR Activation.

Authors:  Belén Borrego; Miguel Rodríguez-Pulido; Concepción Revilla; Belén Álvarez; Francisco Sobrino; Javier Domínguez; Margarita Sáiz
Journal:  Viruses       Date:  2015-07-17       Impact factor: 5.048

4.  Exosomes originating from infection with the cytoplasmic single-stranded RNA virus Rift Valley fever virus (RVFV) protect recipient cells by inducing RIG-I mediated IFN-B response that leads to activation of autophagy.

Authors:  Farhang Alem; Adeyemi A Olanrewaju; Samson Omole; Heather E Hobbs; Noor Ahsan; Graham Matulis; Christine A Brantner; Weidong Zhou; Emanuel F Petricoin; Lance A Liotta; Massimo Caputi; Sina Bavari; Yuntao Wu; Fatah Kashanchi; Ramin M Hakami
Journal:  Cell Biosci       Date:  2021-12-25       Impact factor: 7.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.